>>> GlaxoSmithKline reports EPS in-line, revs in-line; provides FY15 and FY16 gu

--> +4%

GlaxoSmithKline reports EPS in-line, revs in-line; provides FY15 and FY16 guidance
Reports Q2 (Jun) core earnings of GBP0.17 per share, in-line with the Capital IQ Consensus Estimate of GBP0.17; revenues rose 5.9% year/year to GBP5.89 bln vs the GBP5.88 bln consensus.
  • FY15 Guidance: Core EPS for 2015 is expected to decline at a percentage rate in the high teens (Capital IQ consensus -16%) primarily due to continued pricing pressure on Seretide/Advair in US/Europe, the dilutive effect of the Novartis transaction and the inherited cost base of the Novartis businesses.
  • FY16 Guidance: In 2016, GSK expects to see a significant recovery in core EPS with percentage growth expected to reach double digits on a CER basis as the adverse impacts seen in 2015 diminish and the sales and synergy benefits of the Novartis transaction contribute more meaningfully.

>>> RPC misses by $0.05, reports revs in-line (oil&gas services)

RPC misses by $0.05, reports revs in-line

Reports Q2 (Jun) loss of $0.16 per share, $0.05 worse than the Capital IQ Consensus Estimate of ($0.11); revenues fell 48.9% year/year to $297.6 mln vs the $299.11 mln consensus.
  • "RPC's financial results during Q2 of 2015 reflect our industry's declining activity levels and competitive pricing for our services," stated Richard A. Hubbell, RPC's President and Chief Executive Officer.
  • "The average U.S. domestic rig count during Q2 was 907, a decrease of 51.1% compared to the same period in 2014, and a decrease of 35.4% compared to Q1 of 2015. The average price of natural gas was $2.70 per Mcf, a 40.7% decrease compared to the prior year, and a 4.3% decrease compared to Q1 of 2015. The unconventional rig count declined by 45.6% compared to the prior year and 33.1% sequentially. The average price of oil during the quarter was $57.53 per barrel, a 44.3% decrease compared to the prior year but a 17.4% increase compared to the first quarter of 2015. Our sequential revenue decline was slightly less than overall industry declines because of the increasing service intensity of pressure pumping, which is RPC's largest service line."

>>> Altria beats by $0.03, beats on revs; guides FY15 EPS in-line; Announces $1

Altria beats by $0.03, beats on revs; guides FY15 EPS in-line; Announces $1 bln share buyback

Reports Q2 (Jun) earnings of $0.74 per share, excluding non-recurring items, $0.03 better than the Capital IQ Consensus Estimate of $0.71; revenues rose 5.7% year/year to $6.61 bln, which may not be comparable to the $4.75 bln consensus. Co issues in-line guidance for FY15, sees EPS of $2.76-2.81 vs. $2.81 Capital IQ Consensus Estimate. Altria expects its adjusted diluted EPS growth to moderate in the second half of 2015 versus the first-half rate due to several factors. These include lapping the effects of the 2014 improvements in the economy for adult tobacco consumers and lower gasoline prices, expected trade inventory movements and the effect of state excise tax increases. In addition, the comparative benefit from the expiration of the federal tobacco quota buy-out payments ends in the fourth quarter and Altria now estimates its 2015 full-year effective tax rate on operations will be 35.3%.

>>> Praxair reports EPS in-line, misses on revs; guides Q3 EPS below consensus;

Praxair reports EPS in-line, misses on revs; guides Q3 EPS below consensus; lowers FY15 EPS below consensus

  • Reports Q2 (Jun) earnings of $1.45 per share, excluding non-recurring items, in-line with the Capital IQ Consensus of $1.45; revenues fell 12.0% year/year to $2.74 bln vs the $2.85 bln consensus, primarily due to the impact of negative currency translation of 9% and lower cost pass-through of 2%. Organic sales were 1% lower than the prior-year quarter as positive price and new project contribution were offset by weaker underlying industrial activity in Brazil and China and from weaker metals, energy and manufacturing in the United States.
  • Co issues downside guidance for Q3, sees EPS of $1.42-1.49, excluding non-recurring items, vs. $1.57 Capital IQ Consensus Estimate.
  • Co issues downside guidance for FY15, lowers EPS to $5.80-5.95, excluding non-recurring items, from $5.90-6.15 vs. $5.99 Capital IQ Consensus Estimate.

>>> Hilton Hotels beats by $0.02, beats on revs; guides Q3 EPS in-line; raises F

Hilton Hotels beats by $0.02, beats on revs; guides Q3 EPS in-line; raises FY15 EPS in-line

Reports Q2 (Jun) earnings of $0.25 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus Estimate of $0.23; revenues rose 12.2% year/year to $2.99 bln vs the $2.89 bln consensus.
  • Co issues in-line guidance for Q3, sees EPS of $0.21-0.23, excluding non-recurring items, vs. $0.23 Capital IQ Consensus Estimate. System-wide RevPAR is expected to increase between 4.5-6.5% on a comparable and currency neutral basis compared to the third quarter of 2014. Adjusted EBITDA is expected to be between $730 million and $750 million.
  • Co issues raised guidance for FY15, raises EPS to $0.80-0.84 from $0.79-0.83, excluding non-recurring items, vs. $0.82 Capital IQ Consensus Estimate. System-wide RevPAR is expected to increase between 5-7% on a comparable and currency neutral basis. Adjusted EBITDA is projected to be between $2,820 million and $2,870 million,
  • Dividend: Co initiated a regular quarterly cash dividend with the announcement on July 29, 2015 of a dividend of $0.07 per share on shares of its common stock to be paid on or before September 25, 2015.

>>> Huntsman beats by $0.08, misses on revs

Huntsman beats by $0.08, misses on revs
Reports Q2 (Jun) earnings of $0.63 per share, $0.08 better than the Capital IQ Consensus Estimate of $0.55; revenues fell 8.3% year/year to $2.74 bln vs the $3.02 bln consensus.
  • "Our Performance Products and Advanced Materials businesses continue to demonstrate remarkable earnings. Combined, these businesses represent approximately 50% of our adjusted EBITDA; they have EBITDA margins of approximately 20% and low earnings volatility. Their EBITDA grew approximately 20% compared to the prior year and we have growth projects in place for these businesses that are expected to deliver an additional $100 million over the next couple of years."

(TWT) Mark Kleinman: Exclusive: China's HNA Group poised to unveil £2.3bn t...

Mark Kleinman: Exclusive: China's HNA Group poised to unveil £2.3bn takeover of Swissport, the baggage handler at centre of
2015-07-29 10:15:30.881 GMT

Exclusive: China's HNA Group poised to unveil
£2.3bn takeover of Swissport, the baggage
handler at centre of Gatwick crisis last year.
Mark Kleinman @MarkKleinmanSky
 
Sent With: Twitter Web Client
  Original tweet on Twitter.com
found here.

Twitter profile information as of July 29, 2015

Description: City editor of Sky News, City AM columnist and Charlton Athletic
fan. London Press Club Business Journalist of the Year 2011.

Tweets: 4,515  Following: 1,041  Followers: 24,662  Tweeting Since:
9/13/2009  Twitter Verified

-0- Jul/29/2015 10:15 GMT

(BFW) Belgium Has Agreement With Electrabel About Doel 1, 2: Belga

BN 07/29 08:34 *BELGIUM HAS AGREEMENT WITH ELECTRABEL ABOUT DOEL 1, 2: BELGA
Belgium Has Agreement With Electrabel About Doel 1, 2: Belga
2015-07-29 08:36:22.963 GMT


By John Martens
(Bloomberg) -- Belgian Energy Minister Marie-Christine
Marghem, Electrabel conclude negotiations about financial
conditions of lifetime expansion of Doel 1, Doel 2 nuclear
reactors, Belga news agency reports.

Link to Company News:{GSZ FP <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
John Martens at +32-2-285-4303 or
jmartens1@bloomberg.net

(BFW) Hermes to Probe Texas Crocodile Farm After Jane Birkin Complains

BN 07/29 08:35 *HERMES DOESN'T OWN TEXAS FARM, SKINS AREN'T USED FOR BIRKINS
BN 07/29 08:35 *HERMES: ANY BREACHES OF RULES WILL BE SANCTIONED
BN 07/29 08:34 *HERMES IS INVESTIGATING TEXAS FARM IMPLICATED IN VIDEO
BN 07/29 08:34 *HERMES IS ALSO SHOCKED BY IMAGES RECENTLY BROADCAST
BN 07/29 08:33 *HERMES: BIRKIN'S COMMENTS DO NOT INFLUENCE RELATIONSHIP
BN 07/29 08:33 *HERMES COMMENTS IN E-MAILED STATEMENT
BN 07/29 08:33 *HERMES: JANE BIRKIN HAS VOICED CONCERN OVER CROCODILE TREATMENT
Hermes to Probe Texas Crocodile Farm After Jane Birkin Complains
2015-07-29 08:42:14.148 GMT


By Andrew Roberts
(Bloomberg) -- Actress Jane Birkin has expressed concerns
regarding practices for slaughtering crocodiles, Hermes says in
e-mailed statement.

* Her comments do not influence shared friendship and
confidence: Hermes
* Hermes says also shocked by images recently broadcast
* An investigation is underway at Texas farm implicated in
video; any breach of rules will be rectified and sanctioned
* Hermes doesn’t own farm, whose crocodile skins aren’t used
for Birkin bags


Link to Company News:{RMS FP <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Andrew Roberts in Paris at +33-1-5365-5015 or
aroberts36@bloomberg.net

To contact the editor responsible for this story:
Marie Mawad at +33-1-5530-6290 or
mmawad1@bloomberg.net